Levomilnacipran Hydrochloride and Moxetumomab Pasudotox-tdfk
Determining the interaction of Levomilnacipran Hydrochloride and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: levomilnacipran
Brand name: Fetzima
Synonyms: Levomilnacipran
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Levomilnacipran Hydrochloride-Moxetumomab pasudotox-tdfk Intravenous
- Levomilnacipran Hydrochloride-Moxifloxacin
- Levomilnacipran Hydrochloride-Moxifloxacin (Systemic)
- Levomilnacipran Hydrochloride-Moxifloxacin Hydrochloride
- Levomilnacipran Hydrochloride-Moxifloxacin Injection
- Levomilnacipran Hydrochloride-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Levonest
- Moxetumomab Pasudotox-tdfk-Levonorgestrel
- Moxetumomab Pasudotox-tdfk-Levonorgestrel (IUD)
- Moxetumomab Pasudotox-tdfk-Levonorgestrel (Systemic)
- Moxetumomab Pasudotox-tdfk-Levonorgestrel and ethinyl estradiol
- Moxetumomab Pasudotox-tdfk-Levonorgestrel emergency contraceptive